title: [Encephalopathy during oral treatment with bismuth salts].
abstract: Side effects of orally administered bismuthic salts have been known for many years. Many systems are involved, including the digestive and urinary. The authors discuss a recently discovered effect on the central nervous system, termed "bismuth encephalopathy". In the light of the medical literature reviewed, two original aspects are stressed: the clinical symptoms are stereotyped and completely reversible, and the distribution of the disease is almost epidemic, being limited in time and space. The prodromes include confusion, asthenia, slowing of mental functions and disturbance of gait. The clinical picture is dominated by four major symptoms: confusion (again), ataxia, dysarthria and, above all, myoclonic jerks. In conclusion, various pathogenetic hypotheses are considered. The purpose of this study is to enable the general practitioner to detect the development of this condition early in treatment with oral bismuthic salts. Withdrawal of the medication always results in normalization of the patient's condition.
mesh_terms: D000284:Administration, Oral; D001259:Ataxia / Q000139:chemically induced; D001729:Bismuth / Q000008:administration & dosage / Q000009:adverse effects* / Q000378:metabolism; D001927:Brain Diseases / Q000139:chemically induced*; D003221:Confusion / Q000139:chemically induced; D006801:Humans; D009207:Myoclonus / Q000139:chemically induced; D014202:Tremor / Q000139:chemically induced
chemical_list: D001729:Bismuth
vernacular_title: Encéphalopathie au cours des traitements oraux par les sels de bismuth